Evidence map›Paper›PMID 20116195›Full record

ArticleAlcohol (Fayetteville, N.Y.)2010

The role of ethanol metabolism in development of alcoholic steatohepatitis in the rat.

Martin J Ronis, Soheila Korourian, Michael L Blackburn, Jamie Badeaux, Thomas M Badger

Abstract read
In one paragraph

Article in Alcohol (Fayetteville, N.Y.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Disrupted HAntioxidants (Basel, Switzerland) · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Limited Excessive Voluntary Alcohol Drinking Leads to Liver Dysfunction in Mice.Alcoholism, clinical and experimental research · 2017
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Role of Nrf2 in chronic liver disease.World journal of gastroenterology · 2014
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Martin J RonisDepartment of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, 72205, USA. ronismartinj@uams.edu
Soheila Korourian
Michael L Blackburn
Jamie Badeaux
Thomas M Badger
University of Arkansas for Medical Sciences · USArkansas Children's Nutrition Center · US

Funding

ALCOHOL: DIRECT AND INDIRECT EFFECTS ON DRUG METABOLISMR01AA008645 · NIAAA · UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK · PI BADGER, THOMAS M · 1990 to 2008
$2.5M
NIAAA NIH HHS R01 AA008645NIAAA NIH HHS R01 AA08645
6 · The paper itself

Abstract

The importance of ethanol metabolism in the development of alcoholic liver disease remains controversial. The present study examined the effects of selective inhibition of the cytochrome P450 enzyme CYP2E1 compared with the inhibition of overall ethanol metabolism on the development of alcoholic steatohepatitis. Adult male Sprague-Dawley rats were fed via total enteral nutrition for 45 days with or without 10-12g/kg/d ethanol. Some groups were given 200mg/kg/d of the CYP2E1 inhibitor diallyl sulfide (DAS). Other groups were treated with 164mg/kg/d of the alcohol dehydrogenase (ADH) inhibitor 4-methylpyrazole (4-MP) and dosed at 2-3g/kg/d ethanol to maintain similar average urine ethanol concentrations. Liver pathology scores and levels of apoptosis were elevated by ethanol (P<.05) but did not differ significantly on cotreatment with DAS or 4-MP. However, liver triglycerides were lower when ethanol-fed rats were treated with DAS or 4-MP (P<.05). Serum alanine aminotransferase values were significantly lower in ethanol-fed 4-MP-treated rats indicating reduced necrosis. Hepatic oxidative stress and the endoplasmic reticulum (ER) stress marker tribbles-related protein 3 were increased after ethanol (P<.05); further increased by DAS but partly attenuated by 4-MP. Both DAS and 4-MP reversed ethanol increases in the cytokine, tumor necrosis factor-alpha (TNF-alpha), and the chemokine CXCL-2 (P<.05). However, neither inhibitors prevented ethanol suppression of interleukins IL-4 or IL-12. Moreover, neither inhibitors prevented ethanol increases in tumor growth factor-beta mRNA. Ethanol and DAS additively induced hepatic hyperplasia (P<.05). These data suggest that a significant proportion of hepatic injury after ethanol exposure is independent of alcohol metabolism. Ethanol metabolism by CYP2E1 may be linked in part to triglyceride accumulation, to induction of TNF-alpha, and to chemokine production. Ethanol metabolism by ADH may be linked in part to oxidative and ER stress and necrotic injury.

Indexed as

Alcohol DehydrogenaseAllyl CompoundsAnimalsCell DivisionChemokinesCytochrome P-450 CYP2E1Cytochrome P-450 CYP2E1 InhibitorsCytochrome P-450 CYP4AEndoplasmic ReticulumEnzyme InhibitorsEthanolFatty Liver, AlcoholicFomepizoleGene ExpressionLiverMaleAlcohol DehydrogenaseAllyl Compoundsallyl sulfideChemokinesCytochrome P-450 CYP2E1Cytochrome P-450 CYP2E1 InhibitorsCytochrome P-450 CYP4AEnzyme InhibitorsEthanolFomepizolePyrazolesSulfides

Identifiers

PMID20116195
PMCPMC2831169
OpenAlexW2100593358

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.